Evidence map›Paper›PMID 40165782›Full record

ArticleFrontiers in microbiology2025

The changing molecular epidemiology of HIV-1 in Liangshan prefecture, China, in 2021-2023.

Rong Pei, Ling Su, Chunnong Jike, Gang Yu, Ju Wang, Lin Xiao, Yubing Wang, Maogang Shen, Chang Zhou, Jiayi Liao and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Rong PeiNuffield Department of Population Health, Infectious Disease Epidemiology Unit, National Perinatal Epidemiology Unit, University of Oxford, Oxford, United Kingdom.
Ling SuSichuan Provincial Center for Disease Control and Prevention, Center for AIDS/STD Control and Prevention, Chengdu, China.
Chunnong JikeLiangshan Prefecture Centre for Disease Control and Prevention, Xichang, Xichang, China.
Gang YuLiangshan Prefecture Centre for Disease Control and Prevention, Xichang, Xichang, China.
Ju WangLiangshan Prefecture Centre for Disease Control and Prevention, Xichang, Xichang, China.
Lin XiaoLiangshan Prefecture Centre for Disease Control and Prevention, Xichang, Xichang, China.
Yubing WangLiangshan Prefecture Centre for Disease Control and Prevention, Xichang, Xichang, China.
Maogang ShenLiangshan Prefecture Centre for Disease Control and Prevention, Xichang, Xichang, China.
Chang ZhouSichuan Provincial Center for Disease Control and Prevention, Center for AIDS/STD Control and Prevention, Chengdu, China.
Jiayi LiaoSchool of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Yulian ZhangSchool of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Yifei ZhengSchool of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Joris HemelaarNuffield Department of Population Health, Infectious Disease Epidemiology Unit, National Perinatal Epidemiology Unit, University of Oxford, Oxford, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Liangshan Prefecture is one of the areas in China most severely affected by human immunodeficiency virus (HIV), but little is known about the molecular epidemiology of HIV-1 in this area. We aimed to analyze the distribution of HIV-1 genetic variants in Liangshan Prefecture in recent years. Methods: 8,523 blood samples were collected from people living with HIV with treatment failure and newly diagnosed individuals in all 17 counties and cities in Liangshan Prefecture between 2021 and 2023. Results: The majority of study participants were male (66%), farmers (78%) and illiterate (53%). The main HIV-1 transmission routes were heterosexual contact (57%) and injecting drug use (27%). Among the 6,298 successfully obtained Conclusion: Future prevention and control policies need to take these changes into account.

Indexed as

circulating recombinant formsHIV-1molecular epidemiologysubtypeunique recombinant forms

Identifiers

PMID40165782
PMCPMC11955671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.